Methyldioxolan

Patent europeic · EP0501912 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0501912
Numer da la dumonda
EP92810112
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
18-02-1992
Publitgà
02-09-1992
Concedì
14-08-1996
Stritgà
17-02-2012
Motiv
Durada maximala cuntanschida
Classas IPC
C07D 317/22 (2006.01)
C07D 317/72 (2006.01)
C07F 15/00 (2006.01)
A01N 43/28 (2006.01)
C07F 9/50 (2006.01)
Prioritad
CH 572/91 25.02.1991
Lingua da l’annunzia
tudestg
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-02-2012

    Durada maximala cuntanschida

    Published in Swissreg on 20.02.2012

  2. 31-03-2003

    Transferì

    Owner
    Novartis AG, Schwarzwaldallee 215, 4058 Basel → Syngenta Participations AG, Schwarzwaldallee 215, 4058 Basel

    Published in +pat+ No 6 in 2003

  3. 14-02-1997

    Adressa midada

    Owner
    CIBA-GEIGY AG, Klybeckstrasse 141, 4002 Basel → Novartis AG, Schwarzwaldallee 215, 4058 Basel

    Published in PIDTJ No 3 in 1997

  4. 15-08-1996

    Concedì

    Published in PIDTJ No 15 in 1996

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.